Cargando…

Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids

INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease. As a clinical empirical prescription of traditional Chinese medicine, Qushi Huayu decoction (QHD) has attracted considerable attention for its advantages in multi-target treatment of NAFLD. However, the intervention...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Yiming, Wang, Xin, Wu, Qian, Yao, Yichen, Xu, Yuan, Li, Yuanyuan, Feng, Qin, Zhou, Mingmei, Gou, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600383/
https://www.ncbi.nlm.nih.gov/pubmed/37900123
http://dx.doi.org/10.3389/fendo.2023.1272214
_version_ 1785125979566374912
author Ni, Yiming
Wang, Xin
Wu, Qian
Yao, Yichen
Xu, Yuan
Li, Yuanyuan
Feng, Qin
Zhou, Mingmei
Gou, Xiaojun
author_facet Ni, Yiming
Wang, Xin
Wu, Qian
Yao, Yichen
Xu, Yuan
Li, Yuanyuan
Feng, Qin
Zhou, Mingmei
Gou, Xiaojun
author_sort Ni, Yiming
collection PubMed
description INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease. As a clinical empirical prescription of traditional Chinese medicine, Qushi Huayu decoction (QHD) has attracted considerable attention for its advantages in multi-target treatment of NAFLD. However, the intervention mechanism of QHD on abnormal lipid levels and gut microbiota in NAFLD has not been reported. METHODS: Therefore, we verified the therapeutic effect of QHD on high-fat diet (HFD)-induced NAFLD in rats by physiological parameters and histopathological examination. In addition, studies on gut microbiota and serum lipidomics based on 16S rRNA sequencing and ultra-high performance liquid chromatography-mass spectrometry (UPLC-MS) were conducted to elucidate the therapeutic mechanism of NAFLD in QHD. RESULTS: The changes in gut microbiota in NAFLD rats are mainly reflected in their diversity and composition, while QHD treated rats restored these changes. The genera Blautia, Lactobacillus, Allobaculum, Lachnoclostridium and Bacteroides were predominant in the NAFLD group, whereas, Turicibacter, Blautia, Sporosarcina, Romboutsia, Clostridium_sensu_stricto_1, Allobaculum, and Psychrobacter were predominant in the NAFLD+QHD group. Lipid subclasses, including diacylglycerol (DG), triglycerides (TG), phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidic acid (PA), phosphatidylserine (PS), lysophosphatidylinositol (LPI), and phosphatidylglycerol (PG), were significantly different between the NAFLD and the control groups, while QHD treatment significantly altered the levels of DG, TG, PA, lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE), and platelet activating factor (PAF). Finally, Spearman’s correlation analysis showed that NAFLD related differential lipid molecules were mainly associated with the genera of Bacteroides, Blautia, Lachnoclostridium, Clostridium_sensu_stricto_1, and Turicibacter, which were also significantly correlated with the biological parameters of NAFLD. DISCUSSION: Taken together, QHD may exert beneficial effects by regulating the gut microbiota and thus intervening in serum lipids.
format Online
Article
Text
id pubmed-10600383
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106003832023-10-27 Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids Ni, Yiming Wang, Xin Wu, Qian Yao, Yichen Xu, Yuan Li, Yuanyuan Feng, Qin Zhou, Mingmei Gou, Xiaojun Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease. As a clinical empirical prescription of traditional Chinese medicine, Qushi Huayu decoction (QHD) has attracted considerable attention for its advantages in multi-target treatment of NAFLD. However, the intervention mechanism of QHD on abnormal lipid levels and gut microbiota in NAFLD has not been reported. METHODS: Therefore, we verified the therapeutic effect of QHD on high-fat diet (HFD)-induced NAFLD in rats by physiological parameters and histopathological examination. In addition, studies on gut microbiota and serum lipidomics based on 16S rRNA sequencing and ultra-high performance liquid chromatography-mass spectrometry (UPLC-MS) were conducted to elucidate the therapeutic mechanism of NAFLD in QHD. RESULTS: The changes in gut microbiota in NAFLD rats are mainly reflected in their diversity and composition, while QHD treated rats restored these changes. The genera Blautia, Lactobacillus, Allobaculum, Lachnoclostridium and Bacteroides were predominant in the NAFLD group, whereas, Turicibacter, Blautia, Sporosarcina, Romboutsia, Clostridium_sensu_stricto_1, Allobaculum, and Psychrobacter were predominant in the NAFLD+QHD group. Lipid subclasses, including diacylglycerol (DG), triglycerides (TG), phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidic acid (PA), phosphatidylserine (PS), lysophosphatidylinositol (LPI), and phosphatidylglycerol (PG), were significantly different between the NAFLD and the control groups, while QHD treatment significantly altered the levels of DG, TG, PA, lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE), and platelet activating factor (PAF). Finally, Spearman’s correlation analysis showed that NAFLD related differential lipid molecules were mainly associated with the genera of Bacteroides, Blautia, Lachnoclostridium, Clostridium_sensu_stricto_1, and Turicibacter, which were also significantly correlated with the biological parameters of NAFLD. DISCUSSION: Taken together, QHD may exert beneficial effects by regulating the gut microbiota and thus intervening in serum lipids. Frontiers Media S.A. 2023-10-11 /pmc/articles/PMC10600383/ /pubmed/37900123 http://dx.doi.org/10.3389/fendo.2023.1272214 Text en Copyright © 2023 Ni, Wang, Wu, Yao, Xu, Li, Feng, Zhou and Gou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Ni, Yiming
Wang, Xin
Wu, Qian
Yao, Yichen
Xu, Yuan
Li, Yuanyuan
Feng, Qin
Zhou, Mingmei
Gou, Xiaojun
Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
title Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
title_full Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
title_fullStr Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
title_full_unstemmed Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
title_short Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
title_sort qushi huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600383/
https://www.ncbi.nlm.nih.gov/pubmed/37900123
http://dx.doi.org/10.3389/fendo.2023.1272214
work_keys_str_mv AT niyiming qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids
AT wangxin qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids
AT wuqian qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids
AT yaoyichen qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids
AT xuyuan qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids
AT liyuanyuan qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids
AT fengqin qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids
AT zhoumingmei qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids
AT gouxiaojun qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids